Suppr超能文献

游离甲状腺素水平升高预示老年男性痴呆发病率增加:男性健康研究。

Higher free thyroxine levels predict increased incidence of dementia in older men: the Health in Men Study.

机构信息

School of Medicine and Pharmacology, Centre for Medical Research, University of Western Australia, Crawley, Western Australia 6009, Australia.

出版信息

J Clin Endocrinol Metab. 2012 Dec;97(12):E2230-7. doi: 10.1210/jc.2012-2108. Epub 2012 Sep 13.

Abstract

CONTEXT

Both hypothyroidism and subclinical hyperthyroidism hinder cognitive function.

OBJECTIVE

We aimed to determine whether more subtle alterations of thyroid hormone levels predict increased incidence of dementia in aging men.

PARTICIPANTS AND DESIGN

Community-dwelling men aged 70-89 yr participated in this prospective longitudinal study.

MAIN OUTCOME MEASURES

The Standardized Mini-Mental State Examination was performed at baseline (2001-2004), and circulating TSH and free T(4) (FT(4)) were assayed. Men with known thyroid disease or dementia, or Standardized Mini-Mental State Examination scores below 24 were excluded from follow-up. New-onset dementia, defined by International Classification of Disease (ICD) codes, was ascertained using data linkage (2001-2009).

RESULTS

During follow-up, 145 of 3401 men (4.3%) were diagnosed for the first time with dementia. Men who developed dementia had higher baseline FT(4) (16.5 ± 2.2 vs. 15.9 ± 2.2 pmol/liter, P = 0.004) but similar TSH (2.2 ± 1.4 vs. 2.3 ± 1.6 mU/liter, P = 0.23) compared with men who did not receive this diagnosis. After adjusting for covariates, higher FT(4) predicted new-onset dementia (11% increased risk per 1 pmol/liter increase in FT(4), P = 0.005; quartiles Q2-4 vs. Q1: adjusted hazard ratio = 1.76, 95% confidence interval = 1.03-3.00, P = 0.04). There was no association between TSH quartiles and incident dementia. When the analysis was restricted to euthyroid men (excluding those with subclinical hyper- or hypothyroidism), higher FT(4) remained associated with incident dementia (11% increase per unit increment, P = 0.03; Q2-4 vs. Q1: adjusted hazard ratio = 2.02, 95% confidence interval = 1.10-3.71, P = 0.024).

CONCLUSIONS

Higher FT(4) levels predict new-onset dementia in older men, independently of conventional risk factors for cognitive decline. Additional studies are needed to explore potential underlying mechanisms and to clarify the utility of thyroid function testing in older men at risk of dementia.

摘要

背景

甲状腺功能减退症和亚临床甲状腺功能亢进症均会影响认知功能。

目的

本研究旨在明确更细微的甲状腺激素水平变化是否可预测老年男性发生痴呆的风险增加。

参与者和设计

本前瞻性纵向研究纳入了年龄在 70-89 岁的社区居住男性。在基线时(2001-2004 年)进行了标准化简易精神状态检查,检测了循环促甲状腺激素(TSH)和游离甲状腺素(FT4)水平。已知患有甲状腺疾病或痴呆,或简易精神状态检查表评分<24 分的男性被排除在随访之外。采用数据链接(2001-2009 年)确定首次诊断为痴呆的患者。

主要观察指标

采用国际疾病分类(ICD)编码确定新发痴呆。

结果

随访期间,3401 名男性中有 145 名(4.3%)首次被诊断为痴呆。与未被诊断为痴呆的男性相比,发生痴呆的男性基线时 FT4 水平更高[(16.5±2.2)pmol/L 比(15.9±2.2)pmol/L,P=0.004],而 TSH 水平相似[(2.2±1.4)mU/L 比(2.3±1.6)mU/L,P=0.23]。校正混杂因素后,FT4 升高与新发痴呆相关(FT4 每增加 1 pmol/L,风险增加 11%,P=0.005;四分位间距 Q2-4 比 Q1:校正后的危险比=1.76,95%置信区间=1.03-3.00,P=0.04)。TSH 四分位间距与痴呆发生无相关性。当将分析限定于甲状腺功能正常的男性(排除亚临床甲状腺功能亢进或减退患者)时,FT4 升高仍与痴呆发生相关(每增加 1 个单位,风险增加 11%,P=0.03;Q2-4 比 Q1:校正后的危险比=2.02,95%置信区间=1.10-3.71,P=0.024)。

结论

在老年男性中,较高的 FT4 水平可预测新发痴呆,且独立于认知功能下降的传统危险因素。需要进一步研究以探讨潜在的机制,并阐明甲状腺功能检测在痴呆高危老年男性中的应用价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验